Drug information provided by: Merative, Micromedex®
Pirtobrutinib is used to treat mantle cell lymphoma (MCL) that has come back or did not respond to previous treatment and who have received at least 2 types of cancer treatment (eg, BTK inhibitor). This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have received at least 2 types of cancer treatment (eg, BTK inhibitor, BCL-2 inhibitor).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.